Stock WINT WINDTREE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Windtree Therapeutics, Inc.

Equities

WINT

US97382D5014

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-05-02 pm EDT 		5-day change 1st Jan Change
4.33 USD -3.56% Intraday chart for Windtree Therapeutics, Inc. -14.60% -66.54%
Apr. 16 Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 11 North American Morning Briefing : Stock Futures -2- DJ

Evolution of the average Target Price on Windtree Therapeutics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

fd076d79b54.6kmcYZEByvycDCMcRmZ6T-BoxpOVsgBiSVGQh49ErQY.oDryVvJLk6jaRHNfMxYTA78Cjtr-2nYkBDCps8UJwE67PMQv6G-7mvNCRA~8e8c12d8364e94347fbff5c11776729a

Analyst Recommendations on Windtree Therapeutics, Inc.

WINDTREE THERAPEUTICS : Oppenheimer Starts Windtree Therapeutics at Outperform with $8 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
4.33 USD
Average target price
18 USD
Spread / Average Target
+315.70%
High Price Target
18 USD
Spread / Highest target
+315.70%
Low Price Target
18 USD
Spread / Lowest Target
+315.70%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Windtree Therapeutics, Inc.

Oppenheimer

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. WINT Stock
  4. Consensus Windtree Therapeutics, Inc.